KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Capital Expenditures (2016 - 2026)

Encompass Health (EHC) has disclosed Capital Expenditures for 18 consecutive years, with $162.4 million as the latest value for Q1 2026.

  • For Q1 2026, Capital Expenditures changed 0.43% year-over-year to $162.4 million; the TTM value through Mar 2026 reached $735.7 million, up 10.43%, while the annual FY2025 figure was $736.4 million, 14.61% up from the prior year.
  • Capital Expenditures hit $162.4 million in Q1 2026 for Encompass Health, down from $229.3 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $229.3 million in Q4 2025 and bottomed at $99.8 million in Q1 2023.
  • Average Capital Expenditures over 5 years is $159.3 million, with a median of $156.9 million recorded in 2024.
  • Year-over-year, Capital Expenditures dropped 11.6% in 2023 and then surged 39.68% in 2024.
  • Encompass Health's Capital Expenditures stood at $209.2 million in 2022, then rose by 1.2% to $211.7 million in 2023, then fell by 6.14% to $198.7 million in 2024, then rose by 15.4% to $229.3 million in 2025, then fell by 29.18% to $162.4 million in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $162.4 million, $229.3 million, and $187.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.